Proinflammatory cytokines inhibit secretion in rat bile duct epithelium

Gastroenterology

Volumn 121, Issue 1, 2001, Pages 156-169

  Spiral, Carlo ^a   Nathanson, Michael H ^a   Fiorotto, Romina ^a   Duner, Elena ^a   Denson, Lee A ^a   Sanz, Juanita M ^a   Di Virgilio, Francesco ^a   Okolicsanyi, Lajos ^a   Casagrande, Fabio ^a   Strazzabosco, Mario ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE; CHLORIDE ION; CYCLIC AMP; CYTOKINE; DEXTRAN; FLUORESCEIN; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 6; RIBONUCLEASE; SECRETIN; SECRETIN RECEPTOR; TRANSMEMBRANE CONDUCTANCE REGULATOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT; CELL MEMBRANE PERMEABILITY; CHLORIDE TRANSPORT; CHOLESTASIS; CONTROLLED STUDY; CYSTIC FIBROSIS; CYTOKINE RELEASE; DISEASE ASSOCIATION; DISEASE COURSE; ENZYME ACTIVITY; ENZYME IMMUNOASSAY; EPITHELIUM; GENE EXPRESSION; INFLAMMATION; MALE; MICROFLUOROMETRY; NONHUMAN; PH; PRIORITY JOURNAL; RAT; SECRETION;

EID: 0034959516     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2001.25516     Document Type: Article

References (61)

1. Pathobiology of biliary epithelia
2. Disappearing intrahepatic bile ducts: The syndromes and their mechanisms
3. The intrahepatic cholangiopathies
4. Immunological mechanisms of hepatic allograft rejection
5. Immunopathogenesis of autoimmune hepatobiliary disease
6. Identification of cytokine protein expression in human liver allograft rejection: Methods development and expression of IL-1b, IL-6, IFN-γ, and basic fibroblast growth factor
7. Cytokines patterns and cytotoxic mediators in primary biliary cirrhosis
8. Cytokines in primary biliary cirrhosis
9. Bile ductular cholestasis: An ominous histopathologic sign related to sepsis and "cholangitis lenta."
10. Gamma-interferon inhibits secretin-induced choleresis and cholangiocyte proliferation in a murine model of cirrhosis
11. In situ nucleic acid hybridization of cytokines in primary biliary cirrhosis: Predominance of Th1 subset
12. Increased expression of interleukin-6 and tumor necrosis factor-α in pathologic biliary epithelial cells: In situ and culture study
13. i regulation in isolated rat bile duct epithelial cells
14. Effects of ursodeoxycholic acid on intracellular pH in a bile duct epithelium-like cell line
15. - transport in cultured human intrahepatic bile duct cells
16. Control of intracellular pH
17. Chloride currents in primary cultures of rabbit proximal and distal convoluted tubules
18. Isolation of small polarized bile duct units
19. Quantitative assessment of canalicular bile formation in isolated hepatocyte couplets using microscopic optical planimentry
20. - exchange in cholangiocytes
21. Stimulation of the bile duct secretion by glibenclamide in normal and cholestatic rat liver
22. ++ in lymphocytes
23. Cell-permeable indicator for cytosolic chloride
24. - and cell volume
25. Assessment of inflammatory events in epithelial permeability: A rapid screening method using fluorescein dextrans
26. Synergistic effects of interferon γ and tumor necrosis factor α on T84 cell function
27. Development and characterization of polarized primary cultures of rat intrahepatic bile duct epithelial cells
28. Regulation of biliary secretion through apical purinergic receptors in cultured rat cholangiocytes
29. Rat cholangiocytes absorb bile acids at their apical domain via the ileal sodium-dependent bile acid transporter
30. Kinetic and molecular identification of sodium-dependent glucose transporter in normal rat cholangiocytes
31. - exchangers in a rat cholangiocytes cell lines
32. i regulation in isolated bile duct epithelial cells
33. Secretin stimulates exocytosis in isolated bile duct epithelial cells by a cyclic AMP-mediated mechanism
34. Upregulation of secretin receptor gene expression in rat cholangiocytes after bile duct ligation
35. Comparison of Na-K-Cl contransporters
36. + transport mechanisms in medullary thick ascending limb cells
37. Localization of the cystic fibrosis transmembrane conductance regulator in human bile duct epithelial cells
38. - anion exchanger in human liver
39. Quantitative fluorescence measurements of chloride secretion in native airway epithelium from CF and non-CF subjects
40. Purinergic regulation of acid/base transport in human and rat biliary epithelium cell lines
41. Nucleotide receptors activate cation, potassium, and chloride currents in a liver cell line
42. 2+ signaling in rat bile duct epithelia
43. Pathophysiology of the intrahepatic biliary epithelium
44. Hormonal regulation of paracellular permeability in isolated rat hepatocyte couplets
45. Altered expression and function of hepatocyte gap junction after common bile duct ligation
46. Mitosis and apoptosis in the liver of interleukin-6-deficient mice after partial hepatectomy
47. Cytokines and fibrogenesis
48. Intracellular adhesion molecule-1 and MHC antigens on human intrahepatic bile duct cells: Effect of proinflammatory cytokines
49. Tumor necrosis factor and interleukin-1: Cytokines with multiple overlapping biological activities
50. Growth control of human biliary epithelial cells by interleukin-6, hepatocyte growth factor bl, and activin A: Comparison of a cholangiocarcinoma cell line with primary cultures of non-neoplastic biliary epithelial cells
51. Gamma-interferon-mediated down-regulation of electrolyte secretion by intestinal epithelial cells: A local immune mechanism?
52. Interferon-γ directly affects barrier function of cultured intestinal epithelial monolayers
53. Interferon-γ downregulates CFTR gene expression in epithelial cells
54. Bile formation
55. 2+ and CGMP-independent mechanism
56. Hepatocyte tight-junctional permeability is increased in rat experimental colitis
57. Ursodiol for the long-term treatment of primary biliary cirrhosis
58. Liver and biliary problems in cystic fibrosis
59. Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: A placebo-controlled trial
60. Effects of ursodeoxycholic acid after 4 to 12 years of therapy in early and late stages of primary biliary cirrhosis
61. Oral budesonide and ursodeoxycholic acid for treatment of primary biliary cirrhosis: Results of a prospective double-blind trial